Community Clinic Observations Patient Tolerability Protocol: 15 patients escalated from 0.25 mg to 0.5 mg Observations: ~80 % remained on therapy at 12 weeks versus ~60 % retention in historical full-dose records
Read the original article here
Digital health platforms are becoming structural distribution and adherence infrastructure for GLP-1 therapy
Many people are deficient without even knowing itleading to fatigue, muscle cramps, poor sleep, and mood imbalances
SABOR LIMN Ingredientes: protenas de leche , cobertura de chocolate con leche (azcar, manteca de cacao, leche entera en polvo, pasta de cacao, emulgente: lecitina de soja y aroma natural de vainilla), grasa vegetal no hidrogenada de palma, harina de trigo , fructosa, creatina (4,5 %), azcar, manteca de cacao, leche descremada en polvo, L-Carnitina (1,5 %), emulgente (lecitina de soja y e476), aroma de limn, aromas, gasificantes (bicarbonato amnico y bicarbonato sdico), complejo vitamnico [ascorbato sdico (vitamina C), nicotinamida (vitamina B3), acetato de tocoferol (vitamina E), pantotenato clcico (vitamina B5), riboflavina (vitamina B2), piridoxina hidrocloruro (vitamina B6), tiamina mononitrato (vitamina B1), acetato (vitamina A), cido flico (vitamina B9), biotina (vitamina H), ergocalciferol (vitamina D) y cianocobalamina (vitamina B12)] y edulcorante: sucralosa